185 related articles for article (PubMed ID: 22927992)
1. A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.
Poell JB; van Haastert RJ; de Gunst T; Schultz IJ; Gommans WM; Verheul M; Cerisoli F; van Puijenbroek AAFL; van Noort PI; Prevost GP; Schaapveld RQ; Cuppen E
PLoS One; 2012; 7(8):e43569. PubMed ID: 22927992
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cancer aggressive features in melanoma cells by microRNAs.
Greenberg E; Hershkovitz L; Itzhaki O; Hajdu S; Nemlich Y; Ortenberg R; Gefen N; Edry L; Modai S; Keisari Y; Besser MJ; Schachter J; Shomron N; Markel G
PLoS One; 2011 Apr; 6(4):e18936. PubMed ID: 21541354
[TBL] [Abstract][Full Text] [Related]
3. Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.
Barbato A; Iuliano A; Volpe M; D'Alterio R; Brillante S; Massa F; De Cegli R; Carrella S; Salati M; Russo A; Russo G; Riccardo S; Cacchiarelli D; Capone M; Madonna G; Ascierto PA; Franco B; Indrieri A; Carotenuto P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670365
[TBL] [Abstract][Full Text] [Related]
4. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
Chen WY; Xu YY; Zhang XY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma.
Fattore L; Campani V; Ruggiero CF; Salvati V; Liguoro D; Scotti L; Botti G; Ascierto PA; Mancini R; De Rosa G; Ciliberto G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178301
[TBL] [Abstract][Full Text] [Related]
6. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
[TBL] [Abstract][Full Text] [Related]
8. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
Zhang K; Guo L
Gene; 2018 Jan; 641():272-278. PubMed ID: 29054757
[TBL] [Abstract][Full Text] [Related]
9. miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression.
Wang S; Wu Y; Xu Y; Tang X
Gene; 2019 Aug; 710():39-47. PubMed ID: 31129246
[TBL] [Abstract][Full Text] [Related]
10. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
13. Seed targeting with tiny anti-miR-1297 inhibits EMT in melanoma cells.
Han Y; Li X; Ma C; Ji X; Li T; Zheng X; Zhang J; Yan J; Zhang D; Bai J
J Drug Target; 2019 Jan; 27(1):75-81. PubMed ID: 29873263
[TBL] [Abstract][Full Text] [Related]
14. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
Smith JL; Jeng S; McWeeney SK; Hirsch AJ
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
Xiang S; Chen H; Luo X; An B; Wu W; Cao S; Ruan S; Wang Z; Weng L; Zhu H; Liu Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):184. PubMed ID: 30081934
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex.
Greenberg E; Hajdu S; Nemlich Y; Cohen R; Itzhaki O; Jacob-Hirsch J; Besser MJ; Schachter J; Markel G
Open Biol; 2014 Jun; 4(6):140030. PubMed ID: 24920276
[TBL] [Abstract][Full Text] [Related]
18. Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets.
Skourti E; Logotheti S; Kontos CK; Pavlopoulou A; Dimoragka PT; Trougakos IP; Gorgoulis V; Scorilas A; Michalopoulos I; Zoumpourlis V
Mol Carcinog; 2016 Aug; 55(8):1229-42. PubMed ID: 26527515
[TBL] [Abstract][Full Text] [Related]
19. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
Ren JW; Li ZJ; Tu C
Int J Clin Exp Pathol; 2015; 8(6):6356-66. PubMed ID: 26261511
[TBL] [Abstract][Full Text] [Related]
20. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
Liu S; Tetzlaff MT; Cui R; Xu X
Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]